TOKYO -- Countries lacking robust health care systems are starting to adopt COVID-19 vaccines delivered through the nose without needles, providing them with a new tool to combat the pandemic.
No-needle products win approval in India and beyond

Nasal vaccines for influenza have already been approved in the U.S. (Photo courtesy of the U.S. Centers for Disease Control and Prevention)
TOKYO -- Countries lacking robust health care systems are starting to adopt COVID-19 vaccines delivered through the nose without needles, providing them with a new tool to combat the pandemic.